ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS

Xu, Zhiheng; Huang, Yongbo; Zhou, Jianmeng; Deng, Xiumei; He, Weiqun; Liu, Xiaoqing; Li, Yimin; Zhong, Nanshan*; Sang, Ling*广州医学院; 南方医科大学; 1
Frontiers in Immunology2021-10-1DOI: 10.3389/fimmu.2021.738697
13被引10阅读
引用收藏
分享

摘要

The severe respiratory consequences of the coronavirus disease 2019 (COVID-19) pandemic have prompted the urgent need for novel therapies. Cell-based therapies, primarily using mesenchymal stromal cells (MSCs), have demonstrated safety and potential efficacy in the treatment of critical illness, particularly sepsis and acute respiratory distress syndrome (ARDS). However, there are limited preclinical data for MSCs in COVID-19. Recent studies have shown that MSCs could decrease inflammation, improve lung permeability, enhance microbe and alveolar fluid clearance, and promote lung epithelial and endothelial repair. In addition, MSC-based therapy has shown promising effects in preclinical studies and phase 1 clinical trials in sepsis and ARDS. Here, we review recent advances related to MSC-based therapy in the context of sepsis and ARDS and evaluate the potential value of MSCs as a therapeutic strategy for COVID-19.

学科与关键词

关键词
COVID-19MSCs therapiesARDSsepsisSARS-CoV-2
相关
加载中…
  • Mesenchymal stem cell treatment for COVID-19
    Xu, Ruonan*; Feng, Zhiqian; Wang, Fu-Sheng*EBioMedicine, 2022, 77: 103920.被引 32
  • Immune-Cell-Based Therapy for COVID-19: Current Status
    Wang, Yiyuan; Liang, Qinghe; Chen, Fengsheng; Zheng, Jiehuang; Chen, Yan; Chen, Ziye; Li, Ruopeng; Li, Xiaojuan*Viruses-Basel, 2023, 15(11): 2148.
  • Stem cell-based therapy for COVID-19
    Chen, Xiaomei; Liu, Bowen; Li, Chao; Wang, Yulian; Geng, Suxia; Du, Xin; Weng, Jianyu; Lai, Peilong*International Immunopharmacology, 2023, 124: 110890.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2021-10-01
卷期
第 12 卷
页码
738697
DOI
10.3389/fimmu.2021.738697
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81870069, 81970071, 82070084]; Natural Science Foundation of Guangdong Province [2020A1515011459, 2021A1515012565]; Science and Technology Program of Guangzhou [202102010157]; State Key Laboratory of Respiratory Disease Independent Program [SKLRD-Z-202108]; Emergency Key Program of Guangzhou Laboratory [EKPG21-17]

作者

  • X

    Xu, Zhiheng (第一作者)

    guangzhou med univ · 1

  • H

    Huang, Yongbo

    guangzhou med univ · 1

查看全部 9 位作者收起作者
  • Z

    Zhou, Jianmeng

    southern med univ

  • D

    Deng, Xiumei

    guangzhou med univ · 1

  • H

    He, Weiqun

    guangzhou med univ · 1

  • L

    Liu, Xiaoqing

    guangzhou med univ · 1

  • L

    Li, Yimin

    guangzhou med univ · 1

  • Z

    Zhong, Nanshan (通讯)

    guangzhou med univ · 1

  • S

    Sang, Ling (通讯)

    guangzhou med univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417